Interaction of tin(IV) with doxorubicin ‡

Abstract

The first study of the interaction of tin(IV) with the anticancer antibiotic doxorubicin in N,N-dimethylformamide (dmf) solution is reported. Electronic absorption spectroscopy showed that reaction of the drug with SnCl₄ is time dependent and involves the initial formation of a 1∶1 complex. The strong binding was also shown by ¹¹⁹Sn NMR spectroscopy. Reactions with modified anthracyclines show that the α-ketol side chain at C⁹ is essential for interaction, while the quinone chromophore is not involved in binding, as inferred from optical spectroscopy. Proton NMR data suggest that binding to the C⁹ side chain involves enolization at C¹³–C¹⁴. The two-dimensional total correlation spectra indicate that the daunosamine moiety of doxorubicin can be involved in Sn^IV binding with formation of several time-dependent species. This was verified by ¹H and ¹¹⁹Sn NMR studies of Sn^IV–daunosaminide hydrochloride systems. These findings suggest that Sn^IV can bind to doxorubicin at two sites: the C⁹ α-ketol chain, probably after enolization, and the sugar ring at the 4′-OH and 3′-NH₂ positions. This is the first report of metal binding to doxorubicin at the C⁹ side chain.

References

1. J. W. Lown(Editor), Anthracycline and anthracenedione-based anticancer agents, Elsevier, Amsterdam, 1988, vol. 6.
2. S. T. Crooke and S. D. Reich, (Editors), Anthracyclines: current status and new developments, Academic Press, New York, 1980.
3. A. U. Buzdar, C. Marcus, T. L. Smith and G. R. Blumenschein, Cancer, 1985, 55, 2761 and refs. therein.
4. L. J. Steinherz, P. G. Steinherz, C. T. C. Tahn, G. Heller and M. L. Murphy, J. Am. Med. Assoc., 1991, 266, 1672 and refs. therein.
5. F. Villani, E. Monti, L. Favalli, E. Lanza and P. Poggi, IRCS, Med. Sci., 1986, 14, 282.
6. P. A. J. Speth, Q. G. C. M. van Hoesel and C. Haanen, Clin. Pharmacokinet., 1988, 15, 15.
7. A. Garnier-Suillerot, ref. 1, ch. IV, pp. 129–161 and refs. therein.
8. M. M. L. Fiallo and A. Garnier-Suillerot, Biochemistry, 1986, 25, 924.
9. F. Zunino, G. Savi and A. Pasani, Cancer Chemother. Pharmacol., 1986, 18, 180.
10. P. K. Dutta and J. A. Hutt, Biochemistry, 1986, 25, 691.
11. R. E. Lenkinski and S. Sierke, J. Inorg. Biochem., 1985, 24, 59.
12. D. Gelvan, E. Berg, P. Saltman and A. Samuni, Biochem. Pharmacol., 1990, 39, 1289.
13. I. J. McLennan and R. E. Lenkinski, J. Am. Chem. Soc., 1984, 106, 6905.
14. T. Yotsuyanagy, N. Ohta, N. Tanaka and K. Ikeda, Chem. Pharm. Bull., 1990, 38, 3102.
15. H. Beraldo, A. Garnier-Suillerot, L. Tosi and F. Lavelle, Biochemistry, 1985, 24, 284.
16. F. Capolongo, M. Giomini, A. M. Giuliani, B. F. Matzanke, U. Russo, A. Silvestri, A. X. Trautwein and R. Barbieri, J. Inorg. Biochem., 1997, 65, 115.
17. H. B. Haj-Tayeb, M. M. L. Fiallo, A. Garnier-Suillerot, T. Kiss and H. Kozlowski, J. Chem. Soc., Dalton Trans., 1994, 3689.
18. E. Pereira, M. M. L. Fiallo, A. Garnier-Suillerot, T. Kiss and H. Kozlowski, J. Chem. Soc., Dalton Trans., 1993, 455.
19. R. G. Canada and R. G. Carpentier, Biochim. Biophys. Acta, 1991, 1073, 136.
20. G. Bonadonna, Advances in anthracycline chemotherapy: epirubicin, Masson Italia, Milano, 1984.
21. F. Arcamone, Cancer Res., 1985, 45, 5995.
22. W. Priebe, ACS Symp. Ser., 1995, 574.
23. H. Beraldo, A. Garnier-Suillerot and L. Tosi, Inorg. Chem., 1983, 22, 4117.
24. J. J. Zuckermann(Editor), Tin and malignant cell growth, CRC Press, Boca Raton, FL, 1988.
25. M. Gielen, NATO ASI Ser. H, 1990, 37.
26. R. L. Mills, C. W. Walter, L. Venkataraman, K. Pang and J. J. Farrell, Nature, 1988, 336, 787.
27. W. M. Reiff, R. L. Mills and J. J. Farrell, Hyperfine Interact., 1990, 58, 2525.
28. J. W. Lown (Editor), ref. 1, chs. VII, X and XIV.
29. N. Henry, E. O. Fantine, J. Bolard and A. Garnier-Suillerot, Biochemistry, 1985, 24, 7085.
30. S. R. Martin, Biopolymers, 1980, 19, 713.
31. T. Allman and R. E. Lenkinski, Can. J. Chem., 1987, 65, 2405.
32. I. J. McLennan, R. E. Lenkinski and Y. Yanuka, Can. J. Chem., 1985, 63, 1233.
33. R. Mondelli, E. Ragg, G. Fronza and A. Arnone, J. Chem. Soc., Perkin Trans. 2, 1987, 15.
34. F. J. C. Rossotti and H. Rossotti, The determination of stability constants, McGraw-Hill, New York, 1961, pp. 47–51.
35. M. Menozzi, L. Valentini, E. Vannini and F. Arcamone, J. Pharm. Sci., 1984, 73, 766.
36. J. H. Beijnen, O. A. G. J. van der Houwen and W. J. M. Underberg, Int. J. Pharm., 1986, 32, 123.
37. J. Bouma, J. H. Beijnen, A. Bult and W. J. M. Underberg, Pharm. Weekbl. Sci. Ed., 1986, 8, 109.
38. M. M. L. Fiallo, H. Tajeb-Bel Haj and A. Garnier-Suillerot, Metal Based Drugs, 1994, 1, 183.
39. T. Allman and R. E. Lenkinski, J. Inorg. Biochem., 1987, 30, 35.
40. M. Giomini, A. M. Giuliani, M. Giustini and E. Trotta, Biophys. Chem., 1992, 45, 31.
41. V. Cucinotta, A. Gianguzza, G. Maccarrone, L. Pellerito, R. Purrello and E. Rizzarelli, J. Chem. Soc., Dalton Trans., 1992, 2299.